top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Head and Neck Cancer Immunology and Immunotherapy
Advances in Head and Neck Cancer Immunology and Immunotherapy
Autore Abu-Eid Rasha
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 online resource (64 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato cancer immunology
cancer vaccine
head and neck cancer
human leukocyte antigen
Immune check point inhibitor
Immunotharapy
Regulatory T (Treg) cell
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557529703321
Abu-Eid Rasha  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (594 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 1,2,3-triazole
1,3,4-oxadiazole
3-amino-4'-guanidino
3,4'-bis-guanidino
5-fluoruracil
7-deaza-4'-thioadenosine derivatives
acetamide
adamantane
ADC (antibody-drug conjugate)
age
alkylated
anticancer
anticancer activity
anticancer agents
apoptosis
apoptosis induction
aromatase inhibitor
Bcl-2 inhibitors
benzenesulfonamides
benzimidazole
BRAF
breast cancer
cancer
cancer cell viability
cancer vaccine
CAR (chimeric antigen receptor)
cardiotoxicity
carvedilol
cell cycle analysis
chalcone
chalcones
colony formation
combretastatin A-4
concentration-guided dosing
covalent binding
CovDock
cumulative dose
cyclophosphamide
cytotoxic activity
cytotoxic agents
cytotoxicity
designed multiple ligand
diphenyl ether
DNA fragmentation
docking
doxazosin
drug efflux
dual inhibitors
dual-targeting molecule
EGFR
ELISA
enantioselective synthesis
entrectinib
exportin-1
gastric adenocarcinoma
generic product
H1299
HDAC inhibitors
HER2
heterocyclic compound
histopathology
HL-60
HT-29 cells
hybrid compounds
hybrid molecule
hydrazide derivatives
imidazoles
Imiquimod
immunotherapy
in vitro
in vivo
indazole
Indole-based analogues
inflammation
interleukin-6
intramolecular hydrogen bond
isolation
kidney
larotrectinib
letrozole
MD simulations
MDA-MB-231 cells
mechanism prediction
miR-21
mitoxantrone
model informed dosing
MTT cytotoxic assay
MUC1
MUC16
mucin
multi-kinase inhibitor
multidrug resistance
n/a
NaMSA
nitrogen scaffolds
NTRK
nucleoside
oxidative stress
patent review
pemetrexed
phenstatin
phenyl pyridyl ether
physiologically based pharmacokinetics
protein kinase inhibitors
resin acid
solid/lipid nanoparticles
sorafenib
STAT inhibitors
synthesis
TDP1
testis
thieno[2,3-d][1,2,3]triazine
thiourea
thymidylate synthase
tissue-agnostic
Toll-Like Receptor
toxicity
Trk
Trk fusion
trypan blue assay
tryptophanol
tubulin polymerisation inhibitor
tumor spheroids
tyrosil-DNA-phosphodiesterase 1
urinary bladder
USFDA
xanthone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarker Research and Personalized Medicine
Cancer Biomarker Research and Personalized Medicine
Autore Meehan James
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (428 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato 1H-NMR
Akt/mTOR
AmpliSeq
anastomotic leak
autophagy
bioinformatics
biomarker
biomarkers
bladder tumor
breast cancer
cancer biomarkers
cancer vaccine
chemoradiotherapy
chemoresistance
chemotherapy
circulating tumor cells
clear cell renal cell carcinoma
colorectal cancer
comparative oncology
CREB1
cytokine signalling
DNA methylation
drug perturbation
epigenetics
exosomes
FOXO3
gastric cancer
GBP5
glycopeptide
gp130
haptoglobin
head and neck cancer
head and neck squamous cell carcinoma
hepatocellular carcinoma
HNSCC
hormone-dependent carcinogenesis
HPV genotyping
IL13Rα2
IL6ST
immune response
intestinal anastomosis
JAK2
LC-MS/MS
lincRNA-p21
lipidomics
lipoprotein lipase
lipoprotein subfractions
liquid biopsy
liquid-based biomarkers
localized prostate cancer
long non-coding RNA
lymph node metastasis
lymphocyte-to-monocyte ratio
mass spectrometry
meta-analysis
microRNA
middle-up-down
multiphasic multidetector computed tomography
n/a
One Health
ovarian cancer
p16 expression
p53
peripheral blood parameters
personalized medicine
precision medicine
predictive biomarker
predictive tools
prognostic factors
prognostic tools
prostate cancer
radiomics
radioresistance
radiosensitivity biomarkers
radiotherapy
rectal cancer
renal cell carcinoma
saliva
secretome
taxane
telmisartan
tissue-based biomarkers
translational research
transurethral resection
triple-negative breast cancer
tumor recurrence
WHO/ISUP nuclear grade
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674370003321
Meehan James  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato adaptive immunity
anti-CD20 antibody
anti-CTLA-4
anti-PD-1
antibody-dependent cellular cytotoxicity (ADCC)
antigen presenting cells
antigen-presenting cells
Atypical Chemokine Receptor 4 (ACKR4)
B cell aplasia
BAP1
BiFab
bispecific antibody
cancer
cancer stem cells (CSCs)
cancer vaccine
CAR T
carcinoma
CD19-CAR-T
CD28
cell therapy
chemo-enzymatic approach
chemotherapy
classical and endemic Kaposi Sarcoma
colon cancer
colorectal cancer
combination immunotherapy
CTLA-4
cytotoxicity
dendritic cells
differentiation
DNA methylation
epidemiologic studies
Fab
IDO inhibitor
IFN-γ
IL-7
IL15
immune checkpoint blockade
immune checkpoint inhibitors
immune checkpoints
immune evasion
immunomodulation
immunosuppression
immunotherapy
indoleamine 2,3 dioxygenase 1
inhibitory CAR
innate immunity
interferon
KIR
kynurenine pathway
m6A
melanoma
MICA/B mAb
multi-state modelling
n/a
NK cells
NKG2D
organ transplantation
osteoclasts
PD-1
PD-L1
primary liver cancer
prostate cancer
resistance
RNA methylation
S-adenosylmethionine (SAM)
sortase A
systemic treatment
T cells
T-cell priming
TCR diversity
TIL
treatment free interval
Treg cells
triple negative breast cancer
tryptophan 2,3 dioxygenase 2
tumor microenvironment
tumor-infiltrating lymphocytes
uveal
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui

Opere

Altro...

Lingua di pubblicazione

Altro...

Data

Data di pubblicazione

Altro...